SMILE (small heterodimer partner interacting leucine zipper protein) has been identified as a corepressor of the glucocorticoid receptor, constitutive androstane receptor, and hepatocyte nuclear factor 4␣. Here we show that SMILE also represses estrogen receptor-related receptor ␥ (ERR␥) transactivation. Knockdown of SMILE gene expression increases ERR␥ activity. SMILE directly interacts with ERR␥ in vitro and in vivo. Domain mapping analysis showed that SMILE binds to the AF2 domain of ERR␥. SMILE represses ERR␥ transactivation partially through competition with coactivators PGC-1␣, PGC-1␤, and GRIP1. Interestingly, the repression of SMILE on ERR␥ is released by SIRT1 inhibitors, a catalytically inactive SIRT1 mutant, and SIRT1 small interfering RNA but not by histone protein deacetylase inhibitor. In vivo glutathione S-transferase pulldown and coimmunoprecipitation assays validated that SMILE physically interacts with SIRT1. Furthermore, the ERR␥ inverse agonist GSK5182 enhances the interaction of SMILE with ERR␥ and SMILE-mediated repression. Knockdown of SMILE or SIRT1 blocks the repressive effect of GSK5182. Moreover, chromatin immunoprecipitation assays revealed that GSK5182 augments the association of SMILE and SIRT1 on the promoter of the ERR␥ target PDK4. GSK5182 and adenoviral overexpression of SMILE cooperate to repress ERR␥-induced PDK4 gene expression, and this repression is released by overexpression of a catalytically defective SIRT1 mutant. Finally, we demonstrated that ERR␥ regulates SMILE gene expression, which in turn inhibits ERR␥. Overall, these findings implicate SMILE as a novel corepressor of ERR␥ and recruitment of SIRT1 as a novel repressive mechanism for SMILE and ERR␥ inverse agonist.
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Estrogen-related receptors (ERR␣, ERR␤, and ERR␥) 2 are constitutively active nuclear receptors (NRs) that contain high levels of sequence identity to estrogen receptors (ERs)
(1). All the ERR family members bind either as a monomer or a homodimer or as heterodimeric complexes composed of two distinct ERR isoforms to the consensus sequence TCAAGGTCA, referred to as ERR-response element (ERRE), and as homodimers to the consensus estrogen-responsive element (1-3). Together with ERR␣ and ERR␤, ERR␥ regulates a number of genes involved in energy homeostasis, cell proliferation, and cancer metabolism (3, 4). Targets of ERR␥ known to date are PGC-1␣ (peroxisome proliferator-activated receptor ␥ coactivator-1␣), PDK4 (pyruvate dehydrogenase kinase isoform 4), retinoic acid receptor ␣, and cyclin-dependent kinase inhibitors p21 (WAF1/CIP1) and p27 (KIP1) (4 -7). The ability of ERR␥ to regulate target gene transcription relies on its interaction with coactivators and corepressors. The coactivators GRIP1 (glucocorticoid receptor interacting protein 1), PGC-1␣, and corepressors small heterodimer partner (SHP), DAX-1, and RIP140 (receptor interacting protein 140) or NRIP1 have been reported to modulate ERR␥ activity (5, 8 -11) . In addition, 4-hydroxytamoxifen and its derivative GSK5182 act as inverse agonists for ERR␥ (12) (13) (14) . However, the deactivation mechanisms by these inverse agonists remain unclear.
SMILE (small heterodimer partner interacting leucine zipper protein), including two alternative translation-derived isoforms, SMILE-L (CREBZF; long form of SMILE) and SMILE-S (Zhangfei; short form of SMILE), has been classified as a member of the CREB/ATF family of basic region-leucine zipper (bZIP) transcription factors (15, 16). However, SMILE cannot bind to DNA as homodimers, although it can homodimerize like other bZIP proteins (15, 17) . SMILE has been implicated in herpes simplex virus infection cycle and related cellular processes through its association with herpes simplex virus-related host-cell factor and CREB3 (17, 18) . SMILE has also been proposed as a coactivator of activating transcription factor 4 (ATF4/CREB2) (19). Recently, we have reported that SMILE functions as a coregulator of ER signaling and a corepressor of the glucocorticoid receptor (GR), constitutive androstane receptor (CAR), and hepatocyte nuclear factor 4␣ (HNF4␣) (16, 20) . However, the detailed roles of SMILE on other NRs still need to be clarified.
Silent information regulator 2 proteins (Sirtuins) are class III histone protein deacetylases (HDACs) and consist of seven members named SIRT1 to SIRT7 in mammals (21). Through deacetylating target proteins, Sirtuins play important roles in cellular processes such as gene expression, apoptosis, metabolism, and aging (21). Of the seven Sirtuins, SIRT1 has been extensively studied. It has been reported that SIRT1 deacetylates and thereby deactivates the p53 and PARP1 protein (poly-(ADP ribose) polymerase-1), resulting in promoted cell survival (22, 23) . In addition, SIRT1 regulates glucose or lipid metabolism through its deacetylation activity on over 24 known substrates, including FOXO transcriptional factors (24, 25) PPAR␣ (26), PPAR␥ (27), and PGC-1␣ (28). It has also been demonstrated that SIRT1 regulates cholesterol metabolism through deacetylation and activation of liver X receptor proteins (29).
In this study, we have shown that SMILE negatively regulates ERR␥ through direct interaction. We have demonstrated that coactivator competition and recruitment of catalytically active SIRT1 are required for the repression of ERR␥ by SMILE. Moreover, ERR␥-specific inverse agonist GSK5182 enhances the interaction of SMILE and ERR␥. siRNA SMILE and siRNA SIRT1 experiments have revealed that SMILE-SIRT association is required for the inhibition of ERR␥ by GSK5182. In addition, we have observed that ERR␥ induces SMILE gene expression in HepG2 cells by directly binding to the SMILE promoter and that SMILE inhibits ERR␥ transactivation of its own promoter. Overall, our observations suggest that SMILE acts as a novel corepressor of ERR␥ and that ERR␥ belongs to a new autoregulatory loop that governs SMILE gene expression.
EXPERIMENTAL PROCEDURES
Plasmid and DNA Construction-The plasmids of pCMV-␤-gal, pcDNA3-ERR␣, -ERR␤, -ERR␥, -ERR␥⌬AF2, pSG5-HA-ERR␥, pGEX4T-1-ERR␥, and sft4-Luc were described elsewhere (9, 10). (HNF4)8-tk-Luc, pcDNA3-HA-HNF4␣, -PGC-1␣, pSG5-HA-GRIP1, pcDNA3-SMILE, -FLAG-SMLE, -SMILE-83Leu, -SMILE-1Phe, pGEX4T-1, pGEX4T-1-SMILE, pEGFP-SMILE, pEBG, pEBG-SMILE, and pEBG-SMILE deletion constructs SMILE-L(239 -267)V, pSUPER, pSUPER-siSHP, -siSMILE-I, and -siSMILE-II were described previously (2). pcDNA3-FLAG-SIRT6 and -SIRT7 were kindly provided by Dr. Eric Verdin (30). pcDNA3-HA-PGC-1␤, -FLAG-FOXO1, and the reporter PDK4-Luc were kind gifts from Drs. Dieter Kressler (31), Akiyoshi Fukamizu (32), and Robert A. Harris (33), respectively. pcDNA3-FLAG-ERR␣ and -ERR␤ were constructed by inserting the full PCR fragments of the open reading frames into the EcoRI/XhoI sites of pcDNA3-FLAG.pcDNA3-FLAG-ERR␥ was generated via subcloning the full open reading frame of ERR␥ into the EcoRV/XhoI sites of the pcDNA3-FLAG vector. pcDNA3-myc-SIRT1 was constructed via inserting the open reading frame of SIRT1 into pcDNA3-myc vector. pcDNA3-myc-SIRT1H363Y was generated via PCR-mediated site-directed mutagenesis. pSUPER-si-SIRT1 was constructed by inserting a 64-bp double-stranded oligonucleotide containing 5Ј-GAAGTTGACCTCCTCAT-TGT-3Ј of the human SIRT1 cDNA sequence into the pSUPER vector between BglII and XhoI sites. To generate Ϫ1131-bp-SMILE-Luc, the SMILE promoter region spanning Ϫ1131 to Ϫ15 bp was PCR-amplified from human genomic DNA and cloned into pGL3-basic vector (Promega) between the SacI and XhoI sites. Ϫ879-bp-and Ϫ448-bp-SMILE-Luc were constructed by inserting the PCR fragments into the SacI/XhoI sites of pGL3-basic vector. The mutant reporters of SMILEmtERRE1-Luc and SMILE-mtERRE2-Luc were subcloned via site-directed mutagenesis from Ϫ1131-bp-SMILE-Luc. The mutated sequences are shown in Fig. 7D . All plasmids were confirmed via sequencing analysis.
Chemicals and Antibodies-SIRT1 inhibitors nicotinamide and sirtinol were from Calbiochem; EX527 was purchased from TOCRIS; ERR␥ inverse agonist GSK5182 was synthesized according the method described previously (14), and other chemicals were from Sigma. Antibodies used in this work were as follows: anti-FLAG M2 ( Cell Culture, Transient Transfection Assay, and Luciferase Assay-HEK293T (293T, human embryonic kidney), HepG2 (human hepatoma), and HeLa cells (cervical cancer) were obtained from the American Type Culture Collection (ATCC) and cultured according to the manufacturer's instructions. Transient transfection was performed using Superfect transfection reagent (Qiagen) in 293T cells and Lipofectamine 2000 reagent (Invitrogen) in HepG2 cells. 293T and HepG2 cells were cotransfected with the reporter plasmids (HNF4)8-Luc, sft4-Luc, or PDK4-Luc coupled with various expression vectors. The plasmid of cytomegalovirus-␤-galactosidase was cotransfected as an internal control, and the total DNA employed in each transfection was adjusted via the addition of an appropriate quantity of pcDNA3 vector. Approximately 36 h post-transfection, the cells were treated with or without chemicals as indicated in the figure legends for 12 h, and then cells were harvested, and the luciferase activity was measured and normalized against ␤-galactosidase activity as described previously (16, 20) . Fold activity was calculated considering the activity of reporter gene alone as 1.
